404
Synthetic Biology Market Report
The Synthetic Biology Market is Segmented by Tool Type (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids), by Technology Type (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics, and Nanotechnology), by End-Use Industry Type (Medical, Industrial, Food & Agriculture, and Environmental), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)
The Synthetic Biology Market is Segmented by Tool Type (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids), by Technology Type (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mut...
Enquiry Form
Synthetic Biology Market is likely to witness an impressive CAGR of 23.9% during the forecast period. Increasing use of synthetic biology for various applications such as biofuel development, protein therapeutics, personalized medicine, and synthetic drugs & vaccines is one of the prime factors contributing to the demand for synthetic biology. Large scale adoption of synthetic biology coupled with decreasing cost of DNA sequencing & synthesis of genes resulting in increasing investment in companies and start-ups is another crucial factor fueling the growth of the market.
Synthetic Biology Market - Snapshot |
|
Growth |
23.9% for the next five years |
Major Tool Type |
Oligonucleotides & Synthetic DNA |
Dominant Technology Type |
Genome Engineering |
Largest Application Type |
Medical |
Region with the highest demand |
Asia-Pacific |
Key Players |
Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience |
Wish to Get a Free Sample? Register here
Based on the tool type, the market is segmented as oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides & synthetic DNA segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period. The growing demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications is propelling the segment’s market.
Based on the technology type, the synthetic biology market is segmented as gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement & modeling, microfluidics, and nanotechnology. The genome engineering segment is expected to grow at the highest rate in the market, owing to its superior properties as compared to other technologies. Synthetic biology is a preferred choice in genome engineering as it offers ease and efficiency in genome editing and genome targeting.
Based on the end-use industry type, the market is segmented as medical, industrial, food & agriculture, and environmental. The medical segment is expected to grow at the highest rate in the market over the forecast period. With growing population and increased life expectancy comes increased occurrence of disease, which demands better, newer, and more efficient modalities of treatments. Increasing focus towards research & development for better treatments along with huge private and public funding for the discovery of new therapies is a key factor driving the growth of the synthetic biology market for medical applications.
In terms of regions, Asia-Pacific is estimated to be the largest market during the forecast period, with China, Japan, India, and Australia being the major countries with lucrative growth opportunities. This growth can be attributed to the presence of major synthetic biology companies in the region. Availability of funds for research from government organizations, advancing efforts to increase the output of the healthcare industry, rising demand for high-quality research tools for data reproducibility, and increasing focus on development of personalized therapeutics are some prime factors driving the region’s synthetic biology market.
Know which region offers best growth opportunities. Register here
Some key players in the synthetic biology market are Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience.
Synthetic biology is an advanced technology that is developed from biology, engineering, chemistry, and computer science and mainly uses two approaches: top down approach and bottom up approach. The top-down approach involves the re-designing and fabrication of existing biological systems for producing synthetic products, whereas the bottom-up approach involves designing and construction of novel biological systems that do not exist in nature. Aid from government as well as private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors acting as a catalyst towards the imminent need to understand the functioning of genetic elements, cells and biological processes.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
Synthetic Biology Market Research Report - Features |
|
Market Segmentation |
4 |
Regions Covered |
4 |
Countries/Sub-Regions Covered |
17 |
No. of Figures & Tables |
>150 |
Company Profiles |
10 |
The synthetic biology market is segmented into the following categories.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Report Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Market Segmentation
Competitive Benchmarking
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Driven by the factors like Increasing use of synthetic biology for various applications such as biofuel development, the synthetic biology market is expected to grow at a CAGR of 23.9% in the foreseeable years.
Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience are among the key players in the synthetic biology market.
The oligonucleotides & synthetic DNA segment is expected to remain dominant tool type in the synthetic biology market.
Asia-Pacific is expected to remain the largest synthetic biology market during the next five years.
Billing Information
404
We are sorry, Page not found!
The page you are looking for might have been removed had its name changed or is temporarily unavailable.
Back To HomepageMarket Research Reports | Consulting | Insights | Blog | Conferences | Careers | Subscribe | Sitemap | XML
Disclaimer | T&C - Privacy Policy | Cookies | Unsubscribe
© Copyright 2019 Stratview Research. Trademark of Radiant Offshore Consultancy LLP. All Rights Reserved.
Don't want insights worth $20,000 for free?
Give it a Thought!
We are offering insights worth more than $20,000 for Free! Only for registered users.
You will get access to :
Decision Makers / CXO Level Professionals from leading organizations have already started registering!
You can cancel your registration anytime with a single click